Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 17
2021
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
26,107
-14.67%
|
$3,759,408
$144.37 P/Share
|
Aug 17
2021
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,008
+23.94%
|
-
|
Aug 17
2021
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,948
-28.8%
|
$1,576,512
$144.37 P/Share
|
Aug 17
2021
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,686
+42.14%
|
-
|
Aug 17
2021
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
12,934
-8.65%
|
$1,862,496
$144.37 P/Share
|
Aug 17
2021
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Grant, award, or other acquisition
|
Direct |
28,680
+16.09%
|
-
|
Aug 17
2021
|
Marc S. Pritchard Chief Brand Officer |
SELL
Open market or private sale
|
Direct |
13,126
-8.51%
|
$1,890,144
$144.37 P/Share
|
Aug 17
2021
|
Marc S. Pritchard Chief Brand Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,246
+13.59%
|
-
|
Aug 17
2021
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
SELL
Open market or private sale
|
Direct |
926
-10.48%
|
$133,344
$144.37 P/Share
|
Aug 17
2021
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,522
+22.2%
|
-
|
Aug 16
2021
|
Gary A Coombe CEO - Grooming |
SELL
Open market or private sale
|
Direct |
13,360
-100.0%
|
$1,923,840
$144.5 P/Share
|
Aug 16
2021
|
Gary A Coombe CEO - Grooming |
BUY
Exercise of conversion of derivative security
|
Direct |
13,360
+50.0%
|
$1,042,080
$78.66 P/Share
|
Aug 12
2021
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,800
-35.98%
|
$823,600
$142.91 P/Share
|
Aug 11
2021
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
22,344
-58.09%
|
$3,172,848
$142.75 P/Share
|
Aug 11
2021
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,196
+49.82%
|
$2,979,288
$78.66 P/Share
|
Aug 10
2021
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
315,295
-5.45%
|
$44,771,890
$142.15 P/Share
|
Aug 05
2021
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
130
+2.16%
|
-
|
Aug 05
2021
|
Michael G. Homan SVP - Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
262
+2.59%
|
-
|
Aug 04
2021
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
49,899
-29.26%
|
$7,135,557
$143.32 P/Share
|
Aug 04
2021
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Exercise of conversion of derivative security
|
Direct |
49,899
+22.64%
|
$3,892,122
$78.66 P/Share
|
Aug 03
2021
|
Michael G. Homan SVP - Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-51.04%
|
$1,440,000
$144.04 P/Share
|
Aug 03
2021
|
Michael G. Homan SVP - Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+33.79%
|
$850,000
$85.13 P/Share
|
Aug 03
2021
|
Mary Theresa Grabowski Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
15,539
-88.9%
|
$2,222,077
$143.0 P/Share
|
Aug 03
2021
|
Mary Theresa Grabowski Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,539
+47.06%
|
$1,212,042
$78.66 P/Share
|
Aug 03
2021
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,500
-43.26%
|
$500,500
$143.0 P/Share
|
Aug 02
2021
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,465
-97.88%
|
$1,757,565
$141.77 P/Share
|
Aug 02
2021
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,465
+49.46%
|
$947,340
$76.18 P/Share
|
Aug 02
2021
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
14,098
+24.56%
|
-
|
Aug 02
2021
|
Gary A Coombe CEO - Grooming |
SELL
Open market or private sale
|
Direct |
17,872
-100.0%
|
$2,537,824
$142.07 P/Share
|
Aug 02
2021
|
Gary A Coombe CEO - Grooming |
BUY
Exercise of conversion of derivative security
|
Direct |
13,361
+50.0%
|
$1,042,158
$78.66 P/Share
|
Aug 02
2021
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
7,772
-21.53%
|
$1,095,852
$141.77 P/Share
|
Jun 08
2021
|
Bertrand Marc Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
223
+38.85%
|
-
|
Jun 08
2021
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
279
+0.74%
|
-
|
Jun 08
2021
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
297
+0.35%
|
-
|
Jun 08
2021
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
223
+4.66%
|
-
|
Jun 08
2021
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
269
+0.9%
|
-
|
Jun 08
2021
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+0.55%
|
-
|
Jun 08
2021
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
223
+1.11%
|
-
|
Jun 08
2021
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+1.18%
|
-
|
Jun 08
2021
|
Amy Chang Director |
BUY
Grant, award, or other acquisition
|
Direct |
223
+2.73%
|
-
|
May 26
2021
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
3,000
-7.67%
|
$414,000
$138.2 P/Share
|
May 20
2021
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
56,202
-18.92%
|
$7,755,876
$138.5 P/Share
|
May 20
2021
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
56,202
+15.91%
|
$4,777,170
$85.13 P/Share
|
May 17
2021
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,000
-27.05%
|
$417,000
$139.0 P/Share
|
May 12
2021
|
Andre Schulten Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
24,410
-28.07%
|
$3,319,760
$136.29 P/Share
|
May 12
2021
|
Andre Schulten Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,952
+33.4%
|
$1,537,784
$67.52 P/Share
|
May 11
2021
|
Steven D Bishop CEO - Health Care |
SELL
Open market or private sale
|
Direct |
60,000
-50.56%
|
$8,280,000
$138.5 P/Share
|
May 11
2021
|
Steven D Bishop CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+33.58%
|
$4,680,000
$78.66 P/Share
|
May 11
2021
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
3,513
-8.28%
|
$481,281
$137.27 P/Share
|
May 11
2021
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
55,000
-18.63%
|
$7,590,000
$138.25 P/Share
|